Teva Pharmaceutical Industries Stock Market Value

TEVJF Stock  USD 32.84  4.23  14.79%   
Teva Pharmaceutical's market value is the price at which a share of Teva Pharmaceutical trades on a public exchange. It measures the collective expectations of Teva Pharmaceutical Industries investors about its performance. Teva Pharmaceutical is trading at 32.84 as of the 15th of January 2026. This is a 14.79 percent increase since the beginning of the trading day. The stock's lowest day price was 32.84.
With this module, you can estimate the performance of a buy and hold strategy of Teva Pharmaceutical Industries and determine expected loss or profit from investing in Teva Pharmaceutical over a given investment horizon. Check out Teva Pharmaceutical Correlation, Teva Pharmaceutical Volatility and Teva Pharmaceutical Alpha and Beta module to complement your research on Teva Pharmaceutical.
Symbol

Please note, there is a significant difference between Teva Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Teva Pharmaceutical 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Teva Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Teva Pharmaceutical.
0.00
12/16/2025
No Change 0.00  0.0 
In 30 days
01/15/2026
0.00
If you would invest  0.00  in Teva Pharmaceutical on December 16, 2025 and sell it all today you would earn a total of 0.00 from holding Teva Pharmaceutical Industries or generate 0.0% return on investment in Teva Pharmaceutical over 30 days. Teva Pharmaceutical is related to or competes with Coloplast, Orion Oyj, Coloplast, Terumo, Otsuka Holdings, Astellas Pharma, and Straumann Holding. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes gener... More

Teva Pharmaceutical Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Teva Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Teva Pharmaceutical Industries upside and downside potential and time the market with a certain degree of confidence.

Teva Pharmaceutical Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Teva Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Teva Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Teva Pharmaceutical historical prices to predict the future Teva Pharmaceutical's volatility.
Hype
Prediction
LowEstimatedHigh
27.4132.8438.27
Details
Intrinsic
Valuation
LowRealHigh
19.1424.5736.12
Details

Teva Pharmaceutical Backtested Returns

Teva Pharmaceutical appears to be somewhat reliable, given 3 months investment horizon. Teva Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.17, which indicates the firm had a 0.17 % return per unit of risk over the last 3 months. By inspecting Teva Pharmaceutical's technical indicators, you can evaluate if the expected return of 0.95% is justified by implied risk. Please review Teva Pharmaceutical's Risk Adjusted Performance of 0.1211, variance of 30.3, and Coefficient Of Variation of 628.3 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Teva Pharmaceutical holds a performance score of 13. The entity has a beta of -2.51, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Teva Pharmaceutical are expected to decrease by larger amounts. On the other hand, during market turmoil, Teva Pharmaceutical is expected to outperform it. Please check Teva Pharmaceutical's total risk alpha, and the relationship between the standard deviation and rate of daily change , to make a quick decision on whether Teva Pharmaceutical's existing price patterns will revert.

Auto-correlation

    
  0.00  

No correlation between past and present

Teva Pharmaceutical Industries has no correlation between past and present. Overlapping area represents the amount of predictability between Teva Pharmaceutical time series from 16th of December 2025 to 31st of December 2025 and 31st of December 2025 to 15th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Teva Pharmaceutical price movement. The serial correlation of 0.0 indicates that just 0.0% of current Teva Pharmaceutical price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance1.61

Teva Pharmaceutical lagged returns against current returns

Autocorrelation, which is Teva Pharmaceutical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Teva Pharmaceutical's pink sheet expected returns. We can calculate the autocorrelation of Teva Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Teva Pharmaceutical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Teva Pharmaceutical regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Teva Pharmaceutical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Teva Pharmaceutical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Teva Pharmaceutical pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Teva Pharmaceutical Lagged Returns

When evaluating Teva Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Teva Pharmaceutical pink sheet have on its future price. Teva Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Teva Pharmaceutical autocorrelation shows the relationship between Teva Pharmaceutical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Teva Pharmaceutical Industries.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Teva Pink Sheet

Teva Pharmaceutical financial ratios help investors to determine whether Teva Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Teva with respect to the benefits of owning Teva Pharmaceutical security.